A New Hope for Tough-to-Treat Leukemia Patients
In a significant stride for medicine, a new drug combo is showing promise for people with a tough type of blood cancer. The combo, AB8939 plus venetoclax, is showing positive results in four patients who had run out of other options. These patients had a complex form of acute myeloid leukemia (AML),